483 CorneaGen Sep 2021

483 CorneaGen Sep 2021

Peter Kessler FDA$119.00 - Available Now

FDA investigators audited the CorneaGen - Seattle, WA, United States facility and issued inspectional observations (via FDA 483) on 24 Sep 2021.

Product details

  • Category: Biologics
  • Inspection end: 24 Sep 2021
  • Location: Seattle, United States
  • FEI: 3015927085
Add To Cart